An official website of the State of Maryland.

Maryland.gov Translate

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Prescription Drug Affordability Board

Regulations

Proposed Regulations​

Proposed regulations go here

Final Regulations​

Title 14- Independent Agencies

Subtitle 01- Prescription Drug Affordability Board

Chapter

01- General Provisions

              .01 Definitions

              .02 Rules of Constructions

              .03 Open Meetings

              .04 Confidential, Trade-Secret and Proprietary Information

              .05 Public Comment Procedures

              .06 Hearing Procedures​

02- Prescription Drug Affordability Fund

              .01 Prescription Drug Affordability Fund

              .02 Fee Assessment, Exemption, and Collection

              .03 Amount of Assessment

              .04 Use of Funds

              .05 Surplus Funds

03- Public Information Act

              .01 Scope

              .02 Policy

              .03 Definitions

              .04 Official Custodian

              .05 Request for Public Records

              .06 Written Request May Be Required

              .07 Contents of Written Request

              .08 Addressee

              .09 Response to Request

              .10 Notice to Person Potentially Affected by Disclosure

              .11 Electronic Records

              .12 Public Record Destroyed or Lost

              .13 Availability of Judicial and Administrative Review

              .14 Disclosure Against Public Interest

              .15 Fees

              .16 Time and Place of Inspection

              .17 Sociological Information 

04- Cost Review Study Process

              .01 Public Reporting of Drug Affordability Issues

              .02 Identifying Drugs Eligible for Cost Review

              .03 Selecting Drugs for Cost Review

              .04 Request for Information for Cost Review

              .05 Cost Review Study

05- Policy Review, Final Action, Upper Payment Limits Authority

             .01 Definitions

             .02 Criteria for Setting and Upper Payment Limit

             .03 Policy Review and Final Action Process Overview 

             .04 Policy Review–Information Gathering

             .05 Policy Review–Preliminary Policy Recommendations

             .06 Policy Review–Process for Establishing a UPL

             .07 Policy Review–Final Policy Action

             .08 Establishing and Monitoring a UPL

             .09 Reconsideration​

Archived Actions

The Maryland Prescription Drug Affordability Board proposed to adopt new Regulations .01—.04 under a new chapter, COMAR 14.01.06 Implementation and Monitoring of Upper Payment Limits.

The text of the proposed regulations are available in the June 12, 2026 edition of the Maryland Register.

Comments accepted through: 7/13/26